Ocular Therapeutix (OCUL) Net Margin (QoQ) (2014 - 2026)

Ocular Therapeutix (OCUL) Net Margin (QoQ) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Ocular Therapeutix 2.20 Bn 2.20 Bn 11.46 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 24,549.00
Mar 31, 2026 -36,385.00
Dec 31, 2025 -392.00
Sep 30, 2025 3,196.00
Jun 30, 2025 9,029.00
Mar 31, 2025 -25,610.00
Dec 31, 2024 -5,103.00
Sep 30, 2024 -3,460.00
Jun 30, 2024 2,737.00
Mar 31, 2024 -9,237.00
Dec 31, 2023 -4,077.00
Sep 30, 2023 155.00
Jun 30, 2023 3,397.00
Mar 31, 2023 -2,994.00
Dec 31, 2022 4,502.00
Sep 30, 2022 -1,710.00
Jun 30, 2022 -2,774.00
Mar 31, 2022 -2,165.00
Dec 31, 2021 4,807.00
Sep 30, 2021 1,243.00